Cargando…
Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain
Crystal-storing histiocytosis (CSH) is a rare complication of monoclonal gammopathies caused by accumulation of crystalline material inside macrophages, and it may result in a variety of clinical manifestations depending on the involved organs. Although immunoglobulin κ light chains (LCs) seem to be...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616688/ https://www.ncbi.nlm.nih.gov/pubmed/26266355 http://dx.doi.org/10.1097/MD.0000000000001247 |
_version_ | 1782396691316473856 |
---|---|
author | Aline-Fardin, Aude Bender, Sebastien Fabiani, Bettina Buob, David Brahimi, Said Verpont, Marie Christine Mothy, Mohamad Ronco, Pierre Boffa, Jean Jacques Aucouturier, Pierre Garderet, Laurent |
author_facet | Aline-Fardin, Aude Bender, Sebastien Fabiani, Bettina Buob, David Brahimi, Said Verpont, Marie Christine Mothy, Mohamad Ronco, Pierre Boffa, Jean Jacques Aucouturier, Pierre Garderet, Laurent |
author_sort | Aline-Fardin, Aude |
collection | PubMed |
description | Crystal-storing histiocytosis (CSH) is a rare complication of monoclonal gammopathies caused by accumulation of crystalline material inside macrophages, and it may result in a variety of clinical manifestations depending on the involved organs. Although immunoglobulin κ light chains (LCs) seem to be the most frequent pathogenic component, very few molecular data are currently available. A 69-year-old man presented with a very poor performance status. Remarkable features were mesenteric lymph node enlargement and proteinuria, including a monoclonal κ LC. Light and electron microscopy studies revealed the presence of crystals within macrophages in the lymph nodes, bone marrow, and kidney, leading to the diagnosis of CSH. The pathogenic κ LC variable domain sequence was identical to the germline Vk3-20(∗)01/Jk2(∗)01 gene segments, without any somatic mutation, suggesting an extra-follicular B cell proliferation. The patient was successfully treated with 4 cycles of bortezomib and dexamethasone. After a 12-month follow-up, he remains in hematological and renal remission. CSH may present as pseudo-peritoneal carcinomatosis and relate to a monoclonal κ LC encoded by an unmutated gene. Bortezomib-based therapy proved efficacious in this case. |
format | Online Article Text |
id | pubmed-4616688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-46166882015-10-27 Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain Aline-Fardin, Aude Bender, Sebastien Fabiani, Bettina Buob, David Brahimi, Said Verpont, Marie Christine Mothy, Mohamad Ronco, Pierre Boffa, Jean Jacques Aucouturier, Pierre Garderet, Laurent Medicine (Baltimore) 4800 Crystal-storing histiocytosis (CSH) is a rare complication of monoclonal gammopathies caused by accumulation of crystalline material inside macrophages, and it may result in a variety of clinical manifestations depending on the involved organs. Although immunoglobulin κ light chains (LCs) seem to be the most frequent pathogenic component, very few molecular data are currently available. A 69-year-old man presented with a very poor performance status. Remarkable features were mesenteric lymph node enlargement and proteinuria, including a monoclonal κ LC. Light and electron microscopy studies revealed the presence of crystals within macrophages in the lymph nodes, bone marrow, and kidney, leading to the diagnosis of CSH. The pathogenic κ LC variable domain sequence was identical to the germline Vk3-20(∗)01/Jk2(∗)01 gene segments, without any somatic mutation, suggesting an extra-follicular B cell proliferation. The patient was successfully treated with 4 cycles of bortezomib and dexamethasone. After a 12-month follow-up, he remains in hematological and renal remission. CSH may present as pseudo-peritoneal carcinomatosis and relate to a monoclonal κ LC encoded by an unmutated gene. Bortezomib-based therapy proved efficacious in this case. Wolters Kluwer Health 2015-08-14 /pmc/articles/PMC4616688/ /pubmed/26266355 http://dx.doi.org/10.1097/MD.0000000000001247 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4800 Aline-Fardin, Aude Bender, Sebastien Fabiani, Bettina Buob, David Brahimi, Said Verpont, Marie Christine Mothy, Mohamad Ronco, Pierre Boffa, Jean Jacques Aucouturier, Pierre Garderet, Laurent Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain |
title | Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain |
title_full | Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain |
title_fullStr | Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain |
title_full_unstemmed | Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain |
title_short | Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain |
title_sort | pseudo-peritoneal carcinomatosis presentation of a crystal-storing histiocytosis with an unmutated monoclonal κ light chain |
topic | 4800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616688/ https://www.ncbi.nlm.nih.gov/pubmed/26266355 http://dx.doi.org/10.1097/MD.0000000000001247 |
work_keys_str_mv | AT alinefardinaude pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT bendersebastien pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT fabianibettina pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT buobdavid pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT brahimisaid pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT verpontmariechristine pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT mothymohamad pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT roncopierre pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT boffajeanjacques pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT aucouturierpierre pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain AT garderetlaurent pseudoperitonealcarcinomatosispresentationofacrystalstoringhistiocytosiswithanunmutatedmonoclonalklightchain |